$2.98
-0.03 (-1.00%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+604.7% upside
Low Target
$13.91
Average Target
$21.00
High Target
$28.26
Current Price
$2.98
Current
$2.98
$2.98
Target
$21.00
$21.00
$13.91
$21.00 avg
$28.26
Scenario Analysis
Bear Case
$13.91
366.8%
Low target
Base Case
$21.00
+604.7%
Avg target
Bull Case
$28.26
+848.3%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$5.38
-44.6% from high
52-Week Low
$2.01
+48.3% from low
Target vs 52W High
$21.00
+290.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |